A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
Clinical trial NCT03365921 · COMPLETED
Trial details
- NCT number
- NCT03365921
- Sponsor
- Xiamen Innovax Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-27
- Primary completion
- 2019-06-16
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.